As of 2024-09-14, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 17.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.11 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -53.5%.
The range of the Relative Valuation is 12.57 - 22.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 18.2x | 14.1x |
| Forward P/E multiples | 13.3x - 19.1x | 16.0x |
| Fair Price | 12.57 - 22.06 | 17.73 |
| Upside | -67.0% - -42.1% | -53.5% |
| Date | P/E |
| 2024-09-13 | 31.60 |
| 2024-09-12 | 29.61 |
| 2024-09-11 | 29.48 |
| 2024-09-10 | 29.05 |
| 2024-09-09 | 28.78 |
| 2024-09-06 | 28.51 |
| 2024-09-05 | 28.28 |
| 2024-09-04 | 28.71 |
| 2024-09-03 | 28.41 |
| 2024-08-30 | 29.27 |
| 2024-08-29 | 29.14 |
| 2024-08-28 | 28.56 |
| 2024-08-27 | 28.74 |
| 2024-08-26 | 29.02 |
| 2024-08-23 | 28.85 |
| 2024-08-22 | 28.43 |
| 2024-08-21 | 28.55 |
| 2024-08-20 | 28.45 |
| 2024-08-19 | 28.58 |
| 2024-08-16 | 28.17 |
| 2024-08-15 | 28.97 |
| 2024-08-14 | 28.02 |
| 2024-08-13 | 28.31 |
| 2024-08-12 | 28.29 |
| 2024-08-09 | 28.38 |
| 2024-08-08 | 28.25 |
| 2024-08-07 | 28.24 |
| 2024-08-06 | 28.37 |
| 2024-08-05 | 28.62 |
| 2024-08-02 | 29.27 |
| 2024-08-01 | 31.46 |
| 2024-07-31 | 32.07 |
| 2024-07-30 | 29.95 |
| 2024-07-29 | 30.29 |
| 2024-07-26 | 29.52 |
| 2024-07-25 | 28.92 |
| 2024-07-24 | 28.59 |
| 2024-07-23 | 28.66 |
| 2024-07-22 | 28.67 |
| 2024-07-19 | 28.10 |
| 2024-07-18 | 27.61 |
| 2024-07-17 | 27.56 |
| 2024-07-16 | 27.65 |
| 2024-07-15 | 26.83 |
| 2024-07-12 | 26.12 |
| 2024-07-11 | 25.85 |
| 2024-07-10 | 25.39 |
| 2024-07-09 | 24.79 |
| 2024-07-08 | 24.47 |
| 2024-07-05 | 24.94 |